Next Article in Journal
Glucagon in Pediatric Metabolic Disorders: Pathophysiology and Therapeutic Perspectives
Previous Article in Journal
Multisystem Infantile Hemangiomatosis with Cutaneous, Hepatic, and Splenic Involvement
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Role of NLRP3 Inflammasomes in Disorders of Children’s Digestive Systems: A Narrative Review

Faculty of Medicine for Girls, Al-Azhar University, Cairo 4434103, Egypt
Pediatr. Rep. 2025, 17(5), 103; https://doi.org/10.3390/pediatric17050103
Submission received: 12 August 2025 / Revised: 28 September 2025 / Accepted: 29 September 2025 / Published: 7 October 2025

Abstract

Background/Objectives: This review article highlights the role of the nucleotide-binding domain, leucine-rich repeat, pyrin domain-containing 3 protein (NLRP3) inflammasomes in various gastrointestinal and hepatic disorders in the pediatric age group. NLRP3 inflammasomes are one of the principal intracellular innate immune sensors. During inflammation, molecules such as caspase-1 and the release of IL-1β and IL-18 are produced. The NLRP3 inflammasome participates in the preservation of intestinal homeostasis and mucosal immune response. The objective is to evaluate the published articles related to the role of NLRP3 inflammasomes in common pediatric gastrointestinal and hepatic disorders in order to identify the future perspective regarding their possible therapeutic values. Methods: We searched Medline for NLRP3 inflammasomes and disorders of the digestive system during childhood. Results: Although the majority of articles were related to various disorders of adults, such as Alzheimer’s disease, Parkinson’s disease, atherosclerosis, as well as neurodevelopmental disorders, such as schizophrenia, a few published datasets were related to the roles of NLRP3 in the pediatric age group: they addressed autism, rheumatoid arthritis, and other autoimmune diseases, as well as inflammatory bowel diseases (IBD) and hepatic infection. Some research demonstrated that the NLRP3 inflammasome has a protective role; however, it also has a pathogenic function. Conclusions: This review focused on the comprehensive role of inflammasome NLRP3 in the most common pediatric and neonatal gastrointestinal and hepatic diseases, including clinical and experimental studies, as well as the pharmacological inhibitors for NLRP3 inflammasomes, which may provide future therapy for GIT problems, such as IBD.
Keywords: inflammasomes NLRP3; neonates; pediatrics; gastrointestinal and hepatic diseases; NLRP3 inhibitors; gap NLRP3 inflammasomes NLRP3; neonates; pediatrics; gastrointestinal and hepatic diseases; NLRP3 inhibitors; gap NLRP3

Share and Cite

MDPI and ACS Style

ELMeneza, S. Role of NLRP3 Inflammasomes in Disorders of Children’s Digestive Systems: A Narrative Review. Pediatr. Rep. 2025, 17, 103. https://doi.org/10.3390/pediatric17050103

AMA Style

ELMeneza S. Role of NLRP3 Inflammasomes in Disorders of Children’s Digestive Systems: A Narrative Review. Pediatric Reports. 2025; 17(5):103. https://doi.org/10.3390/pediatric17050103

Chicago/Turabian Style

ELMeneza, Safaa. 2025. "Role of NLRP3 Inflammasomes in Disorders of Children’s Digestive Systems: A Narrative Review" Pediatric Reports 17, no. 5: 103. https://doi.org/10.3390/pediatric17050103

APA Style

ELMeneza, S. (2025). Role of NLRP3 Inflammasomes in Disorders of Children’s Digestive Systems: A Narrative Review. Pediatric Reports, 17(5), 103. https://doi.org/10.3390/pediatric17050103

Article Metrics

Back to TopTop